|
|
颅内动脉病变导致缺血性卒中的治疗现状
|
Abstract:
缺血性脑卒中作为一种拥有极高发病率和致残率的疾病，给患者家庭和社会带来巨大的经济负担。有报道称颅内动脉粥样硬化病每年发生缺血性中风的风险 > 20%，高度狭窄(70%~99%)的患者风险更大，在亚洲人群中此种疾病占所有中风的30%~50%，影响远高于其他种族。伴随着近年来影像技术的迅速发展，血管内治疗也逐渐成为一种有价值和有效的选择，但由于华法林–阿司匹林治疗症状性颅内动脉狭窄(Warfarin Aspirin Symptomatic Intracranial Disease, WASID)研究以及颅内支架置入术和积极药物干预治疗颅内动脉狭窄(Stenting and Aggressive Medical Management for the Prevention of stroke in Intracranial Stenosis, SAMM-PRIS)研究并未能取得预期结果，目前针对慢性缺血的最佳治疗方案仍值得商榷。本文回顾了近年来发表的重要文献，旨在针对目前颅内动脉病变导致缺血性卒中的治疗方案进行综述。
Ischemic stroke, as a disease with high incidence and disability rate, brings huge economic burden to the patients’ families and society. It has been reported that the annual risk of ischemic stroke in intracranial atherosclerosis is more than 20%, and patients with high stenosis (70%~99%) are at greater risk. This disease accounts for 30%~50% of all strokes in Asian populations and the impact is much higher than that of other races. With the rapid development of imaging technology in recent years, endovascular therapy has gradually become a valuable and effective choice. However, due to the study of warfarin aspirin symptomatic intracranial disease (WASID) and stenting and aggressive medical management for the prevention of stroke in intracranial stenosis (SAMM-PRIS), the best treatment for chronic ischemia is still open to question. This article reviews the important literature published in recent years in order to review the current treatment of ischemic stroke caused by intracranial arterial lesions.
| [1] | 彭斌, 吴波. 中国急性缺血性脑卒中诊治指南2018 [J]. 中华神经科杂志, 2018, 51(9): 666-682. |
| [2] | Thomalla, G., Simonsen, C.Z., Boutitie, F., et al. (2018) MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset. The New England Journal of Medicine, 379, 611-622. https://doi.org/10.1056/NEJMoa1804355 |
| [3] | Chimowitz, M., Lynn, M.J., Howlett-Smith, H., et al. (2005) Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis. The New England Journal of Medicine, 352, 1305-1316.
https://doi.org/10.1056/NEJMoa043033 |
| [4] | Wang, Y., Meng, R., Liu, G., et al. (2019) Intracranial Atherosclerotic Disease. Neurobiology of Disease, 124, 118-132.
https://doi.org/10.1016/j.nbd.2018.11.008 |
| [5] | Krasteva, M.P., Lau, K.K., Mordasini, P., et al. (2020) Intracranial Atherosclerotic Stenoses: Pathophysiology, Epidemiology, Risk Factors and Current Therapy Options. Advances in Therapy, 37, 1829-1865.
https://doi.org/10.1007/s12325-020-01291-4 |
| [6] | Chimowitz, M.I., Lynn, M.J., Derdeyn, C.P., et al. (2011) Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis. The New England Journal of Medicine, 365, 993-1003. https://doi.org/10.1056/NEJMoa1105335 |
| [7] | Nordmeyer, H., Chapot, R. and Haage, P. (2019) Endovascular Treatment of Intracranial Atherosclerotic Stenosis. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 191, 643-652.
https://doi.org/10.1055/a-0855-4298 |
| [8] | Lall, A., Yavagal, D.R. and Bornak, A. (2021) Chronic Total Occlusion and Spontaneous Recanalization of the Internal Carotid Artery: Natural History and Management Strategy. Vascular, 29, 733-741.
https://doi.org/10.1177/1708538120978043 |
| [9] | Szarek, M., Amarenco, P., Callahan, A., et al. (2020) Atorvastatin Reduces First and Subsequent Vascular Events across Vascular Territories: The SPARCL Trial. Journal of the American College of Cardiology, 75, 2110-2118.
https://doi.org/10.1016/j.jacc.2020.03.015 |
| [10] | Yeo, S.H., Toh, M., Lee, S.H., et al. (2020) Impact of Medication Nonadherence on Stroke Recurrence and Mortality in Patients after First-Ever Ischemic Stroke: Insights from Registry Data in Singapore. Pharmacoepidemiology and Drug Safety, 29, 538-549. https://doi.org/10.1002/pds.4981 |
| [11] | Campbell, B.C., Mitchell, P.J., Kleinig, T.J., et al. (2015) Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. The New England Journal of Medicine, 372, 1009-1018.
https://doi.org/10.1056/NEJMoa1414792 |
| [12] | Goyal, M., Demchuk, A.M., Menon, B.K., et al. (2015) Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. The New England Journal of Medicine, 372, 1019-1030. https://doi.org/10.1056/NEJMoa1414905 |
| [13] | Saver, J.L., Goyal, M., Bonafe, A., et al. (2015) Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke. The New England Journal of Medicine, 372, 2285-2295. https://doi.org/10.1056/NEJMoa1415061 |
| [14] | Lu, J. and Wang, D. (2016) Advances in Endovascular Therapy for Ischemic Cerebrovascular Diseases. Chronic Diseases and Translational Medicine, 2, 135-139. https://doi.org/10.1016/j.cdtm.2016.11.005 |
| [15] | Albers, G.W., Lansberg, M.G., Kemp, S., et al. (2017) A Multicenter Randomized Controlled Trial of Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke (DEFUSE 3). International Journal of Stroke: Official Journal of the International Stroke Society, 12, 896-905. https://doi.org/10.1177/1747493017701147 |
| [16] | Jovin, T.G., Saver, J.L., Ribo, M., et al. (2017) Diffusion-Weighted Imaging or Computerized Tomography Perfusion Assessment with Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention with Trevo (DAWN) Trial Methods. International Journal of Stroke: Official Journal of the International Stroke Society, 12, 641-652. https://doi.org/10.1177/1747493017710341 |
| [17] | 刘新峰, 孙文, 朱武生, 等. 中国急性缺血性脑卒中早期血管内介入诊疗指南2018 [J]. 中华神经科杂志, 2018, 51(9): 683-691. |
| [18] | Wu, C., Chang, W., Wu, D., et al. (2019) Angioplasty and/or Stenting after Thrombectomy in Patients with Underlying Intracranial Atherosclerotic Stenosis. Neuroradiology, 61, 1073-1081. https://doi.org/10.1007/s00234-019-02262-5 |
| [19] | Amarenco, P., Lavallée, P.C., Monteiro, T.L., et al. (2018) Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. The New England Journal of Medicine, 378, 2182-2190. https://doi.org/10.1056/NEJMoa1802712 |
| [20] | Fischer, U., Hsieh-Meister, K., Kellner-Weldon, F., et al. (2020) Symptomatic and Asymptomatic Intracranial Atherosclerotic Stenosis: 3 Years’ Prospective Study. Journal of Neurology, 267, 1687-1698.
https://doi.org/10.1007/s00415-020-09750-2 |
| [21] | Zhang, Y., Sun, Y., Li, X., et al. (2020) Early versus Delayed Stenting for Intracranial Atherosclerotic Artery Stenosis with Ischemic Stroke. Journal of Neurointerventional Surgery, 12, 274-278.
https://doi.org/10.1136/neurintsurg-2019-015035 |
| [22] | Zhang, J., Zhang, X., Zhang, J.P., et al. (2018) Endovascular Recanalisation with Drug Coated Balloon for Chronic Symptomatic Middle Cerebral Artery Total Occlusion. Journal of Neurointerventional Surgery, 10, e24.
https://doi.org/10.1136/neurintsurg-2017-013693.rep |
| [23] | Ma, L., Liu, Y.H., Feng, H., et al. (2019) Endovascular Recanalization for Symptomatic Subacute and Chronic Intracranial Large Artery Occlusion of the Anterior Circulation: Initial Experience and Technical Considerations. Neuroradiology, 61, 833-842. https://doi.org/10.1007/s00234-019-02205-0 |
| [24] | Yu, J.Z., Sun, S.Y., Jon, S.J., et al. (2019) Endovascular Recanalization of Symptomatic Non-Acute Intracranial Artery Occlusion: Procedural and Mid-Term Clinical Outcomes in the Anterior Circulation. Interventional Neuroradiology: Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences, 25, 380-389.
https://doi.org/10.1177/1591019919826616 |
| [25] | Hoving, J.W., Marquering, H.A. and Majoie, C. (2017) Endovascular Treatment in Patients with Carotid Artery Dissection and Intracranial Occlusion: A Systematic Review. Neuroradiology, 59, 641-647.
https://doi.org/10.1007/s00234-017-1850-y |
| [26] | Banerjee, C. and Chimowitz, M.I. (2017) Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circulation Research, 120, 502-513. https://doi.org/10.1161/CIRCRESAHA.116.308441 |
